Boston Scientific Corp (BSX)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NYSE
Market cap: $63.11B
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Latest financial period: June 30, 2026
Filed with the SEC: August 3, 2026
Estimated earnings date: October 28, 2026
Profit #710 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 10.3% | 9.6% | 8.6% | 8.7% |
Growth #651 of 1484 companies
Payout #1117 of 1484 companies
Safety #125 of 1484 companies
Price #393 of 1484 companies
